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Comparative Genomics Identifies the Mouse Bmp3
Promoter and an Upstream Evolutionary Conserved
Region (ECR) in Mammals
Jonathan W. Lowery, Anna W. LaVigne, Shoichiro Kokabu, Vicki Rosen*
Department of Developmental Biology, Harvard School of Dental Medicine, Boston, Massachusetts, United States of America
Abstract
The Bone Morphogenetic Protein (BMP) pathway is a multi-member signaling cascade whose basic components are found
in all animals. One member, BMP3, which arose more recently in evolution and is found only in deuterostomes, serves a
unique role as an antagonist to both the canonical BMP and Activin pathways. However, the mechanisms that control BMP3
expression, and the cis-regulatory regions mediating this regulation, remain poorly defined. With this in mind, we sought to
identify the Bmp3 promoter in mouse (M. musculus) through functional and comparative genomic analyses. We found that
the minimal promoter required for expression in resides within 0.8 kb upstream of Bmp3 in a region that is highly conserved
with rat (R. norvegicus). We also found that an upstream region abutting the minimal promoter acts as a repressor of the
minimal promoter in HEK293T cells and osteoblasts. Strikingly, a portion of this region is conserved among all available
eutherian mammal genomes (47/47), but not in any non-eutherian animal (0/136). We also identified multiple conserved
transcription factor binding sites in the Bmp3 upstream ECR, suggesting that this region may preserve common cis-
regulatory elements that govern Bmp3 expression across eutherian mammals. Since dysregulation of BMP signaling appears
to play a role in human health and disease, our findings may have application in the development of novel therapeutics
aimed at modulating BMP signaling in humans.
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Introduction
The Bone Morphogenetic Protein (BMP) pathway is a signaling
cascade that has ancient origins in the evolution of animals, arising
1.2–1.4 billion years ago [1,2]. Canonical BMP signaling occurs
through BMP ligand interaction with a complex of type I and type
II BMP receptors, leading to activation of a class of downstream
transcription factors (SMADs in vertebrates, MAD in Drosophila,
SMA in C. elegans). Strikingly, this basic mechanism is highly
conserved across all animals [2] and, as no non-animal counter-
parts have been identified, the BMP pathway is likely a key
advancement in the evolution of animals.
Although the first observation of BMP activity in mammals was
its ability to induce ectopic bone formation [3], BMP signaling has
since been implicated in the development of nearly all vertebrate
organs and is required for some of the earliest developmental
processes, including gastrulation and axis determination [4,5].
Thus, it is not surprising that BMP signaling is tightly regulated at
many levels. For instance, extracellular antagonists that sequester
BMP ligands away from BMP receptors (eg, Noggin) and E3-
ubiquitin ligases (eg, SMURF1) that promote degradation of BMP
receptors and SMADs [6,7] are ancestral mechanisms for reducing
BMP pathway activation that are conserved as early as sponges
[2].
Arising more recently in evolution, the BMP ligand BMP3
serves a unique function by antagonizing the canonical BMP and
Activin pathways. Homologs of BMP3 have only been identified in
deuterostomes, but are present as early as echinoderms (sea urchin
[8]) and hemichordates (acorn worm (Acorn Worm Genome
Project, Baylor). Though the mature domains of the prototypical
BMP ligands BMP2/4 and BMP5/6/7 (Dpp and Gbb in
Drosophila, respectively) share dramatic identity, BMP3 is highly
divergent from other BMP ligands in that it falls into an
intermediate phylogenetic clade between TGF-b/Activin and
BMP ligands [9,10] and shares only 40% amino acid identity with
the ancestral BMP2/4 and BMP5/6/7 groups [11]. For many
years after its identification, mammalian BMP3 was thought to
function like a typical BMP ligand [12,13]. However, more recent
in vivo analyses suggest that BMP3 serves an inhibitory function.
For instance, while BMP ligands promote osteogenesis [14], Bmp3
knockout mice have high bone mass, indicating that BMP3 acts as
a negative regulator of osteogenesis in vivo [15]. Moreover, BMP3
inhibits BMP2-induced differentiation of osteoprogenitors into
osteoblasts, the cells which produce bone matrix [15,16,17,18].
These findings have been extended to overexpression studies in
chick [19], Xenopus [20,21], and mouse [22], all of which
consistently indicate that BMP3 negatively regulates the BMP
and Activin pathways. While the precise mechanism for this
inhibition remains unclear, BMP3 has been demonstrated to both
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sequester BMP receptors into inactive signaling complexes [15,20]
through high affinity interaction with the receptor ACVR2B
[17,23,24] and lead to altered TGF-b/Activin signaling
[15,16,24,25,26], which commonly antagonizes BMP-mediated
effects [27,28,29,30,31,32,33,34,35,36,37,38].
Despite significant progress in distinguishing BMP3 as a unique
inhibitory ligand among BMPs, the mechanisms that regulate
BMP3 expression are unclear. For instance, BMP3 exhibits a
restricted expression pattern in vivo
[17,19,25,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54] and
its expression is modulated by several pathways
[25,41,52,55,56,57,58,59,60], yet the cis-regulatory elements
mediating these effects remain largely unknown. With this goal
in mind, we sought to identify the Bmp3 promoter in mouse (M.
musculus) through functional and comparative genomic analyses.
Having found that the minimal promoter resides within 0.8 kb
upstream of Bmp3 in M. musculus, we also identified a highly
conserved element (ECR) upstream of the homologous Bmp3 locus
in every available eutherian mammal genome but not in any non-
eutherian animal. We determined the minimal ECR that is
present in all reference eutherian mammal genomes and identified
the transcription factor binding sites conserved between M.
musculus, rat (R. norvegicus), and human (H. sapiens). Collectively,
our findings suggest that the high level of conservation of the Bmp3
upstream ECR may preserve common cis-regulatory elements that
govern Bmp3 expression across eutherian mammals.
Materials and Methods
Plasmid construction
A series of plasmids containing fragments from the region
upstream of Bmp3 in M. musculus were generated from M. musculus
genomic DNA using primer pairs as detailed in Table S1. For
identification of the Bmp3 minimal promoter, genomic fragments
contained the first 63 nt of Bmp3 exon 1 in order to include the
annotated Bmp3 transcription start site. For directional cloning
into pGL4.14 (Promega), which is a promoter-less plasmid that
encodes firefly luciferase, or pGL4.26 (Promega), in which firefly
luciferase is under the control of the herpes simplex virus
Thymidine Kinase minimal promoter, 59 XhoI and 39 HindIII
restriction enzyme cut sites were appended to the genomic
fragment by PCR. For directional cloning into pJL114, in which
firefly luciferase is controlled upstream of the Bmp3 minimal
promoter in pJL114, 59 SacI and 39 XhoI restriction enzyme cut
sites were appended to the genomic fragment by PCR. Ligation
was performed using DNA Ligation Kit (Takara) at 16uC for thirty
minutes and transformed into OneShot TOP10 E. coli (Invitrogen)
using the manufacturers9 protocol.
Cell culture and in vitro experiments
HEK293T, UMR-106, and C2C12 cells were obtained from
ATCC; primary calvarial osteoblasts were isolated from newborn
wild type mice as described by Owen & Pan [61]. All cells were
maintained in DMEM GlutaMAX (Gibco) supplemented with
10% FBS (Gibco).
For RT-PCR analyses, cells were scraped into PBS, centrifuged
for 5 min at 500 x g at 4uC, the PBS aspirated, then cells were
lysed and RNA collected using the RNeasy Mini Kit (QIAGEN)
according to the manufacturer’s protocol. cDNA was synthesized
using the Transcriptor First Strand cDNA Synthesis Kit (Roche)
according to the manufacturer’s protocol. Newborn mouse hind
limb RNA (collected as per animal protocol #04043 issued to VR
with approval by the Harvard Medical Area Institutional Animal
Care and Use Committee) served as a positive control. PCR on
cDNA was performed using OneTaq polymerase (NEB) according
to the manufacturer’s protocol. RT-PCR primers were designed to
be complementary to M. musculus, R. norvegicus, and H. sapiens and
cross exon boundaries (Bmp3: 59-GGCTCTATGACAGGTA-
CAGC-39 and 59-CTTTGGCATGGGGAACTGGCA-39, Hprt:
59-CCTGCTGGATTACATTAAAGCACTG-39 and 59-
GTCAAGGGCATATCCAACAACAAAC-39).
Luciferase activity was assayed using the Dual-Glo Luciferase
Assay System (Promega). Cells were seeded at 3 k/cells per well in
a 96-well plate. The next day, a plasmid encoding Renilla
luciferase (pGL4.73, Promega) and test plasmids driving firefly
luciferase were co-transfected into cells using XtremeGENE
(Roche). After 48-hours, firefly and Renilla luciferase activity
was quantified using a luminometer (LumiCount, Packard);
expression of firefly luciferase under the control of the CMV
promoter served as a positive control. Experiments were
performed in triplicate or greater and are expressed as mean6-
SEM firefly luciferase/Renilla luciferase ratio. Data were normal-
ized to the promoter-less (pGL4.14) or Thymidine Kinase minimal
promoter (pGL4.26) control firefly luciferase plasmids.
In silico experiments
DNA sequences were aligned using BLASTN [62] Version
2.2.266 or ECR Browser [63] through the respective online
servers or locally using MUSCLE in MEGA5 software [64].
Accession number and region of DNA used for these analyses are
denoted in the text and/or tables/figures. All analyses were
performed between June and August 2012 using database versions
current to that time period. The consensus Bmp3 upstream
minECR was constructed using the Los Alamos National
Laboratory’s Simple Consensus Maker (http://www.hiv.lanl.
gov/content/sequence/CONSENSUS/consensus.html) using
‘‘Output aligned’’ parameter. For identification of transcription
factor binding sites, DNA sequences were first aligned using
zPicture [65] then transferred to rVista 2.0 [66]. Transcription
factor affinity prediction was performed using TRAP [67,68] using
‘‘transfac_2010.1 vertebrates’’ matrix, ‘‘mouse_promoters’’ back-
ground model, and Benjamini-Hochberg multiple test correction.
DNA repeat motifs were identified using EMBL-EBI’s CENSOR
database [69] using the parameter ‘‘Mammalian.’’ Unless
otherwise noted, all analyses were carried out using the default
parameters.
Statistical Analysis
Statistical significance was determined by One-way ANOVA
with post hoc Newman-Keuls correction for multiple pairwise
comparisons using GraphPad Prism. A p value of ,0.05 was
considered significant.
Results
Conservation analysis of the Bmp3 upstream region
To identify the M. musculus Bmp3 promoter, we first used ECR
Browser [63] to analyze the regions of high nucleotide conserva-
tion upstream of the Bmp3 transcription start site between M.
musculus and the closely related R. norvegicus. This revealed a high
level of nucleotide identity ($75% across sliding 100 nt window)
in the approximately 1.9 kb region proximal to the annotated
transcription start site of M. musculus Bmp3 (Figure 1). Within this
region, there are two large blocks of $80% identity: a proximal
one spanning from positions 21 to 2806 and a distal one
spanning positions 21057 to 21945. Each of these also contains a
smaller region of $90% identity: 21 to 2167 and 21408 and
21571, respectively. The nucleotide identity between M. musculus
Identification of a Bmp3 ECR in Mammals
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and R. norvegicus drops sharply upstream of this region, becoming
more conserved once again beyond 3.2 kb upstream; this poorly
conserved region is also present when aligning M. musculus and the
alternate R. norvegicus reference genome, indicating this finding is
not due to an assembly error (JWL, data not shown).
Functional identification of the M. musculus Bmp3
promoter and an upstream repressive element
Due to the close evolutionary-relatedness of M. musculus and R.
norvegicus, we predicted that the M. musculus Bmp3 promoter would
reside within the conserved region that abuts the Bmp3 transcrip-
tion start site instead of farther upstream in the poorly conserved
region. We established a reporter system using HEK293T cells
wherein firefly luciferase expression is controlled by fragments
from the putative M. musculus Bmp3 promoter. We first confirmed
that HEK293T cells express Bmp3 basally (Figure S1A), making
them a suitable system in which to study the Bmp3 promoter.
Driving firefly luciferase expression by increasingly larger
fragments of the putative Bmp3 promoter demonstrated that the
proximal, highly conserved block 0.800 kb upstream of Bmp3 is
the minimal region necessary for expression (Figure 2A). To
evaluate the potential action of this genomic region in osteoblasts,
we utilized the osteoblast-like UMR-106 osteosarcoma cell line
[70] and primary mouse calvarial osteoblasts, both of which
express Bmp3 basally (Figure S1B-C and [60]). Consistent with our
findings in HEK293T cells, the 0.800 kb upstream of Bmp3 is
sufficient to drive firefly luciferase expression in these cells
(Figure 2B–C). Specific promoter activity of the 0.800 kb region
was demonstrated by its inability to drive firefly luciferase
expression in C2C12 myoblast cells (Figure 2D), which do not
express Bmp3 (Figure S1D). rVista2.0 [66] analysis of this 800 nt
region (hereafter referred to as the Bmp3 minimal promoter)
identified binding sites for a number of general (eg, TFII-I) and
pathway-specific transcription factors (eg, SMAD, TCF/LEF, AP-
1, STAT, and KF-kappaB), many of which are conserved with R.
norvegicus (Table S2). We then performed TRanscription factor
Affinity Prediction (TRAP) analyses [67,68] to examine each
predicted site based upon strength of binding affinity (Table S2).
Having identified the minimal promoter for M. musculus Bmp3,
we turned our attention to the distal conserved block and
intervening sequence (IvS) between the distal and proximal blocks
(Figure 1 and Figure 2A). We did not observe promoter activity
when attempting to drive firefly luciferase expression with the
highest conserved portion of the distal block (Figure 2A). Rather,
appending the distal block and IvS to the Bmp3 minimal promoter
reduced the promoter activity (Figure 2A), indicating that a
portion of this ,1 kb region upstream of the minimal promoter
acts as a basal repressive element in HEK293T cells. In support of
this finding, rVista 2.0 analysis identifies binding sites for a number
of potential repressive transcription factors (Table S2). To
determine if the repressive action of this region is specific to
HEK293T cells, we examined its function in UMR-106 cells,
primary mouse calvarial osteoblasts, and C2C12 cells. In each cell
type, the ,1 kb region upstream of the Bmp3 minimal promoter
acted as a repressive element, though this did not reach statistical
significance in primary osteoblasts (Figure 2B–D).
Identification of an evolutionary conserved region (ECR)
upstream of Bmp3 in mammals
The high degree of identity in the distal block/IvS between M.
musculus and R. norvegicus raises the possibility that this could be an
evolutionary conserved region (ECR) that regulates the expression
of Bmp3. However, the overall level of conservation between M.
musculus and R. norvegicus is too high to allow us to make this
conclusion. For this reason, we extended our nucleotide conser-
vation analysis by performing pairwise alignments of the Bmp3
upstream regions between M. musculus and more distantly related
species. We were unable to use ECR Browser for these analyses as
the species that are aligned to M. musculus in this database are
limited. Instead, we performed alignments using BLASTN in
sequential 500 nt sections from M. musculus against the full-length
5 kb region upstream of Bmp3 from the other species. This
approach also allowed for the possibility of genomic insertions or
deletions. To ensure the fidelity and accuracy of these analyses, we
focused our attention on the thirty-nine NCBI Reference
Sequence (RefSeq) animal genomes, at least twenty-eight of which
contain an annotated Bmp3 or Bmp3-like gene.
As proof of principle, the highest identity to M. musculus was
found among the other two muroideans, R. norvegicus and Chinese
hamster (C. griseus) (Figure 3A and Table S3). Strikingly, among
mammals more distantly related to M. musculus, we found the
highest degree of conservation when using a portion of the distal
Figure 1. Conservation of the genomic region upstream of Bmp3 in M. musculus and R. norvegicus. A: Composite image adapted from ECR
Browser aligning the regions upstream of the Bmp3 transcription start site between M. musculus and R. norvegicus. Threshold was set to $75%
identity across sliding 100 nt window. This revealed a highly conserved 1.9 kb region proximal to the annotated transcription start site of M. musculus
Bmp3. Within this region, there are two large blocks of $80% identity: a proximal one spanning from positions 21 to 2806 and a distal one spanning
positions 21057 to 21945. Each of these also contain a smaller region of $90% identity: 21 to 2167 and 21408 and 21571, respectively. Genomic
coordinates refer to location on M. musculus NC_000071.6. Gray bars indicate aligned segment. Purple boxes indicate repeat elements in M. musculus.
Black region indicates 59-end of Bmp3 exon 1 in M. musculus.
doi:10.1371/journal.pone.0057840.g001
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conserved block upstream of Bmp3 in M. musculus (Figure 3A–C
and Table S3). This pattern was present in every eutherian
mammal in our cohort (15/15), but in neither of the non-eutherian
mammals, M. domestica and O. anatinus (Figure 3D and Table S3),
nor in any of the twenty-two non-mammalian RefSeq genomes
(JWL, data not shown).
These findings suggested that all or a portion of the distal block
conserved between M. musculus and R. norvegicus upstream of Bmp3
is an ECR among eutherian mammals. To test this directly, we
first aligned the region upstream of Bmp3 in M. musculus and H.
sapiens using ECR Browser [63]. Setting our threshold at 77%
identity across a sliding 350 nt window to pinpoint lengthy, highly
conserved ‘‘CoreECRs’’ [63], we identified a 505 nt region in M.
musculus spanning from position 21642 to 21138 upstream of the
Bmp3 transcription start site that is within the distal block
conserved between M. musculus and R. norvegicus (Figure 4A). The
absolute position of the CoreECR is 98852797–98853301 on
NC_000071.6. This is the only CoreECR conserved between M.
musculus and H. sapiens within 7.6 kb upstream and 30 kb
downstream of the Bmp3 locus (JWL, data not shown).
To determine the function of the Bmp3 CoreECR, we generated
plasmids in which portions of the repressive distal block/IvS
region were placed upstream of the Bmp3 minimal promoter. This
revealed that the CoreECR is as effective as the complete ,1 kb
region in its ability to repress the Bmp3 minimal promoter
(Figure 4B).
We then used BLASTN to align the M. musculus: H. sapiens
CoreECR sequence to all thirty-nine available animal RefSeq
genomes, revealing significant conservation of this sequence in all
(15/15) eutherian mammals (Table S4); in each, the conserved
region was upstream of Bmp3. Moreover, although the Bmp3 gene
has been found in at least eleven of the non-eutherian animals in
the RefSeq genome database, the Bmp3 upstream ECR was not
found in any of the twenty-four non-eutherian animal RefSeq
genomes analyzed (JWL, data not shown).
Determination of the minimal Bmp3 upstream ECR
(minECR)
We have demonstrated that an ECR shared with M. musculus lies
upstream of Bmp3 in each eutherian mammal in the RefSeq
genome database. However, the total length and identity of the
Figure 2. Functional characterization of the genomic region upstream of M. musculus Bmp3. A–D: Regulation of firefly luciferase activity
driven by fragments from the region upstream of M. musculus Bmp3 in HEK293T cells (A), UMR-106 cells (B), primary calvarial osteoblasts (C), and
C2C12 cells (D). All data are mean6SEM normalized to promoter-less control. p,0.05 as determined by One-way ANOVA with post hoc Newman-
Keuls correction is indicated by ‘‘a’’ versus promoter-less control and by ‘‘b’’ versus 20.800 kb fragment.
doi:10.1371/journal.pone.0057840.g002
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Bmp3 upstream ECR varies (Table S4), prompting us to determine
the minimal ECR that is conserved across all eutherian mammals
in the RefSeq cohort. To do so, the full-length ECRs from each
species were aligned using MUSCLE in MEGA5 [64], identifying
a minimal Bmp3 upstream ECR (minECR) with a consensus
length of 297 nt (Figure 5). The mean identity to the consensus
minECR is 90% (range: 79%–97%, median: 92%) (Table 1); the
individual nucleotide conservation is shown in Figure S2.
The relative genomic location of the Bmp3 upstream minECR
varies from species to species, but is quite consistent among
closely-related species (Table 1). We found the 59-end of the Bmp3
upstream minECR to be as close as position 2741 in E. caballus
and as distant as position 22772 in C. jacchus (Table 1). To
determine if the minECR retains the repressive activity of the full-
length CoreECR, we placed both sequences upstream of the
Thymidine Kinase minimal promoter. This revealed that the both
were capable of repressing the Thymidine Kinase minimal
Figure 3. Conservation of the region upstream of Bmp3 between M. musculus and RefSeq mammal genomes. Pairwise alignments were
performed between the Bmp3 upstream regions of M. musculus and all seventeen available RefSeq mammalian genomes (15 eutherian, 2 non-
eutherian) using BLAST 2.2.26+. Comparing sequential 500 nt sections from M. musculus against the full-length 5 kb region upstream of Bmp3 from
the other species allowed for the possibility of genomic insertions or deletions. Findings are separated into taxonomic classification for clarity (A–D).
Actual numbers for these analyses are listed in Table S3. Conservation with R. norvegicus, H. sapiens, and B. taurus are based upon the primary
assembly.
doi:10.1371/journal.pone.0057840.g003
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promoter, but the activity of the longer CoreECR was slightly
stronger than the minECR (Figure 5B).
We analyzed the consensus minECR sequence using CENSOR
[69] to identify potential DNA repeat elements, which revealed a
reverse-orientation, partial match to the Short Interspersed
Element (SINE) MIRb (Figure S2). However, inspection of the
minECR from each individual species shows that this partial
repeat is predominantly found in primates, and it resides in one of
the more poorly aligned regions of the consensus minECR- the
mean identity to this 57 nt region is 88%, and removing it from
the consensus minECR increases the overall identity in 11/16
species, raising the mean identity to 91%. For this reason, and the
small size of this partial repeat region relative to the full minECR,
we do not credit the high conservation of the Bmp3 upstream
minECR across eutherian mammals to a conserved retrotranspo-
son.
Additionally, we confirmed that the Bmp3 minECR resides in a
non-coding region of the genome by performing BLASTN
alignment of the consensus Bmp3 upstream minECR against the
database of GenBank/EMBL/DDBJ expressed sequence tags
(ESTs), which comprise .73,580,051 sequences. This failed to
identify any EST with significant alignment to the consensus Bmp3
upstream minECR- the highest identity was 85% over 59 nt (JWL,
data not shown). For comparison, exon 1 of M. musculus Bmp3
readily aligned to multiple ESTs from M. musculus and other
species (JWL, data not shown).
Identification of the consensus Bmp3 upstream minECR
in all available eutherian mammal genomes
Our findings suggest that the Bmp3 upstream ECR is a cis-
regulatory element unique to eutherian mammals. However, since
the number of RefSeq genomes is fairly small at present, we
extended our investigation to species for which a RefSeq genome
is not available. We used BLASTN to align the consensus Bmp3
upstream minECR to the whole-genome shotgun sequence
database, which comprises 191 animal species. This revealed
significant conservation of the Bmp3 upstream minECR in thirty-
one of thirty-nine eutherian mammals that were not represented
by the RefSeq cohort (Table S5); notably, at the present stage of
their assembly, there is no identifiable Bmp3 gene in any of the
Figure 4. Identification of a repressive CoreECR upstream of Bmp3 between M. musculus and H. sapiens. A: Image adapted from ECR
Browser aligning the regions upstream of the Bmp3 transcription start site between M. musculus and H. sapiens. Threshold was set to $77% identity
across sliding 350 nt window. This revealed a CoreECR upstream of the annotated transcription start site of Bmp3 in both species (blue region –M.
musculus: 98852797–98853301 on NC_000071.6; H. sapiens: 81949936–81950336 on NC_000004.11). Genomic coordinates refer to location on M.
musculus NC_000071.6. Gray bar indicates aligned segment. Purple boxes indicate repeat elements in M. musculus. Black region indicates 59-end of
Bmp3 exon 1 in M. musculus. B: Regulation of firefly luciferase activity driven by fragments from the region upstream of M. musculus Bmp3 in HEK293T
cells. minP = minimal promoter; IvS = intervening sequence between distal and proximal conserved blocks. Data are mean6SEM normalized to
promoter-less control. p,0.05 as determined by One-way ANOVA with post hoc Newman-Keuls correction is indicated by ‘‘a’’ versus promoter-less
control and by ‘‘b’’ versus 20.800 kb fragment.
doi:10.1371/journal.pone.0057840.g004
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eight eutherian mammals in which the Bmp3 upstream ECR was
not identified. Moreover, although the Bmp3 gene has been found
in at least sixteen non-eutherian animals in this databse, the Bmp3
upstream minECR was not found in any of the 136 non-eutherian
animal genomes analyzed (JWL, data not shown).
Identification of transcription factor binding sites in the
consensus Bmp3 upstream ECR
Next, we turned our focus to examining the potential cis-
regulatory role(s) played by the Bmp3 upstream ECR. To do so, we
first used rVista 2.0 to identify the transcription factor binding sites
(TFBSs) in the consensus Bmp3 minECR sequence (Table S6).
This yielded a list of fifty-one distinct binding sites, the majority of
which are estimated to be high affinity by TRAP analysis and are
pathway-specific transcription factors (eg, C/EBP, Ikaros, AP1).
Finally, we sought to validate the evolutionary conservation of
the Bmp3 upstream minECR as a cluster of cis-regulatory elements
by determining the degree to which conserved cis-regulatory
elements exist outside of the minECR. To do so, we aligned the
regions upstream of M. musculus and H. sapiens, then identified
conserved transcription factor binding sites using rVista 2.0 (Table
S7). This revealed that, with the exception of one (STAT3), all of
the transcription factor binding sites within 2 kb upstream of Bmp3
in M. musculus that are conserved with H. sapiens reside within the
M. musculus: H. sapiens CoreECR (Figure 6 and Table S7).
Moreover, sixteen of the twenty (80%) transcription factor binding
sites conserved between M. musculus and H. sapiens upstream of
Bmp3 reside within the limits of the minECR, and all but one
(USF) are present in the consensus minECR sequence (Figure 6
and Table S7). For secondary confirmation of this finding, we
aligned the regions upstream of Bmp3 from M. musculus, R.
norvegicus, C. griseus, and Guinea pig (C. porcellus). This revealed that
all of the TFBSs within 3.8 kb upstream of Bmp3 that are
conserved across the RefSeq rodent genomes (9/9) reside within
the limits of the minECR and are present in the consensus
minECR sequence (JWL, data not shown). These findings indicate
that the consensus minECR could serve as a valid predictor of
highly conserved cis-regulatory elements that govern Bmp3
expression.
Discussion
In the present study, we took a comparative genomics approach
to identify potential cis-regulatory elements controling Bmp3
expression in M. musculus. Functional characterization of various
genomic fragments revealed the 0.8 kb region proximal to the
annotated M. musculus Bmp3 transcription start site to be the
minimal promoter in HEK293T cells, UMR-106 osteosarcoma
cells, and primary calvarial osteoblasts. This region corresponds to
a highly conserved block ($80% identity across a sliding 100 nt
window) that is shared between M. musculus and R. norvegicus and
contains binding sites for a number of both general and pathway-
specific transcription factors. We analyzed the 5 kb upstream
region and exon 1 of Bmp3 from M. musculus using Neural Network
Promoter Scan [71] to identify potential transcription starts sites
(TSSs) within the minimal promoter. This revealed two TSSs
Figure 5. Examination of the minimal Bmp3 upstream ECR (minECR) present in all RefSeq mammals. BLASTN (Version 2.2.26+) was used
to align the M. musculus: H. sapiens CoreECR sequence to all sixteen available eutherian mammal RefSeq genomes in order to identify the Bmp3
upstream ECR shared with M. musculus. Each full-length ECR was then aligned using MUSCLE in MEGA5 [64], identifying a minimal Bmp3 upstream
ECR (minECR) with a consensus length of 297 nt. The mean identity to the consensus minECR is 90% (range: 79%–97%, median: 92%); the individual
nucleotide conservation is shown in Figure S2. Uppercase letters in the consensus sequence indicate 100% conservation, while lowercase letters
indicate the majority nucleotide; ‘‘n’’ indicates no consensus nucleotide could be determined. B: Regulation of Thymidine Kinase minimal promoter
(TK minP) by fragments from the region upstream of M. musculus Bmp3 in HEK293T cells. Data are mean6SEM normalized to promoter-less control.
p,0.05 as determined by One-way ANOVA with post hoc Newman-Keuls correction is indicated by ‘‘a’’ versus promoter-less control and by ‘‘b’’ versus
CoreECR fragment.
doi:10.1371/journal.pone.0057840.g005
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(20.108 kb and 20.452 kb) upstream of exon 1. These two TSSs,
in addition to the annotated TSS, are contained in our luciferase
reporter plasmids. Thus, we are unable to determine which TSS is
used in each cell type; however, the 0.8 kb fragment consistently
led to induction of luciferase expression in each of our assays
whereas shorter fragments did not, leading us to conclude that we
have identified the minimal region necessary to drive Bmp3
expression. Our findings are consistent with a previous report that
attained promoter activity using the 2 kb region upstream of Bmp3
in R. norvegicus [25].
We were surprised to find that the Bmp3 minimal promoter is
poorly conserved between M. musculus and H. sapiens, although this
finding is consistent with a previous report comparing the
promoter for Bmp3b (also known as GDF10) between M. musculus
and H. sapiens [9]. While Bmp3b likely arose from duplication of the
Bmp3 gene, or vice versa [9,72], alignment of the 5 kb regions
upstream of Bmp3 and Bmp3b in M. musculus failed to demonstrate
any significant nucleotide identity (JWL, data not shown),
suggesting that Bmp3 and Bmp3b have evolved unique mechanisms
regulating their expression. This idea is supported by the fact that
the spatio-temporal expression domains of Bmp3 and Bmp3b differ
quite drastically [72].
After identifying the proximal block conserved between M.
musculus and R. norvegicus as the minimal promoter, we turned our
attention to the remaining highly conserved region (21.9 kb to
20.8 kb upstream of Bmp3). Interestingly, appending this region to
Table 1. Conservation of the consensus minimal Bmp3 upstream Evolutionary Conserved Region (minECR) in RefSeq animal
genomes.
Accession Number minECR Distance from Bmp3 (nt)
Location % Identity 59 39
Rodentia M. musculus NC_000071.6 95552942.95553250 79% 21497 21189
R. norvegicus NC_005113.3 12332541.12332253, complement 82% 21511 21223
AC_000082.1 10827337.10827049, complement 82% 21511 21223
C. porcellus NT_176414.1 5088909.5089198 80% 21789 21500
C. griseus NW_003616697.1 55307.54999, complement 82% 21611 21303
Primates H. sapiens NC_000004.11 81950009.81950305 97% 22110 21814
AC_000136.1 77693899.77694195 97% 22111 21815
P. troglodytes NC_006471.3 49002602.49002306, complement 97% 22101 21805
P. abelii NC_012595.1 84489849.84490145 97% 22120 21824
M. mulatta NC_007862.1 48535985.48535688, complement 96% 22137 21840
N. leucogenys NW_003501411.1 13030680.13030976 96% 22109 21813
C. jacchus NC_013898.1 113372870.113372574, complement 96% 22772 22476
Other Orders B. taurus AC_000163.1 97583173.97583469 93% 22360 22064
NC_007304.5 99175053.99175349 93% 22360 22064
S. scrofa NC_010450.3 146200934.146200644, complement 78% 21914 21624
C. lupus familiaris NC_006614.2 8169902.8170198 87% 22135 21839
A. melanoleuca NW_003217292.1 2528248.2527953, complement 92% 22167 21872
E. caballus NC_009146.2 55766669.55766369, complement 90% 2741 2441
O. cuniculus NC_013683.1 69240613.69240317, complement 86% 22347 22051
Species are separated by taxonomic order. Distance from Bmp3 is calculated from the annotated transcription start site. nt: nucleotide.
doi:10.1371/journal.pone.0057840.t001
Figure 6. Transcription factor binding sites conserved between M. musculus and H. sapiens in the Bmp3 upstream region. Transcription
factor binding sites in the 1.797 kb genomic fragment were identified using rVista 2.0 for M. musculus and H. sapiens. With the exception of one, all
transcription factor binding sites within 2 kb upstream of Bmp3 that are conserved between M. musculus and H. sapiens lie within the CoreECR.
Transcription factor binding sites in red are also conserved with the consensus Bmp3 upstream minECR. Drawn to scale using the M. musculus
1.797 kb genomic fragment from Figure 1.
doi:10.1371/journal.pone.0057840.g006
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the minimal promoter repressed promoter activity. Fidelity of the
genomic fragment in this reporter plasmid was confirmed by bi-
directional sequencing and our finding was consistent in each
repetition of our assay, leading us to conclude that this region is
capable of repressing basal Bmp3 expression in each cell type
tested. This is supported by the fact that, when we examined
potential TFBSs in this region by rVista2.0 [66] analysis, we
identified binding sites for a number of potential repressive
transcription factors.
BLASTN alignment of the 5 kb regions between M. musculus
and each of the other thirty-nine complete RefSeq genomes
revealed that a portion of the distal block was conserved with every
eutherian mammal (15/15), but not in any non-eutherian species
(0/24) even though a Bmp3 or Bmp3-like locus has been annotated
for at least thirteen non-eutherian species (eg, X. tropicalis, D. rerio,
G. gallus, O. anatinus, M. domestica). We went on to narrow this
conserved region to 297 nt that is shared between all eutherian
mammals in the RefSeq cohort, and then found this minimal ECR
in thirty-one additional eutherian mammals represented in the
whole-genome shotgun sequence (WGS) database (total of forty-
seven eutherian mammals between RefSeq and WGS databases).
As with the RefSeq database, we did not find the minimal ECR in
any of the 136 non-eutherian animal genomes in the WGS
database. Of note, genomic sequences are presently available from
only four non-eutherian mammals (O. anatinus, M. domestica, M.
eugenii and S. harissii). Thus, we conclude from our findings that the
Bmp3 upstream ECR is a eutherian mammal-specific cis-element,
but are aware that future studies are required to definitively show
if this ECR is also found in metatherian or prototherian mammals.
The Bmp3 upstream minECR is a highly conserved genomic
region near the minimal promoter that represses basal promoter
activity. This arrangement is similar to the conserved, high GC-
content short-range repressive elements that have been described
near the Bmp2 promoter [73] –though the Bmp3 upstream
minECR bears no alignment to these regions and the GC content
is only 45% (JWL, data not shown). To examine possible
regulatory mechanisms, we examined the Bmp3 upstream
minECR using rVista 2.0, which not only pinpoints consensus
TFBSs using the TRANSFAC database but combines this
information with sequence conservation analyses of the surround-
ing 20 nt to identify the most biologically relevant TFBSs [66],
and TRAP analysis, which predicts transcription factor binding
affinity to each site [67,68]. This revealed that sixteen of the
twenty (80%) transcription factor binding sites conserved between
M. musculus and H. sapiens upstream of Bmp3 reside within the
limits of the minECR, and the majority of these are predicted to be
high-affinity binding sites. Moreover, even among the more
closely-related rodents M. musculus, R. norvegicus, C. griseus, and C.
porcellus we found that all of the TFBSs within 3.8 kb upstream of
Bmp3 (9/9) reside within the limits of the minECR (JWL, data not
shown).
Our identification of a highly conserved block of potential cis-
regulatory elements upstream of Bmp3 in mammals provides a
foundation for future studies examining modulation of Bmp3
expression. In support of this, the TFBSs that we identified are
highly consistent with what has previously been reported on the
regulation of Bmp3. For instance, binding sites for HNF1, VDR,
AP1, and NF-kappaB, all of which have been shown to regulate
Bmp3 expression [25,52,55,57,60], are present in the Bmp3
upstream minECR.
Of particular interest to us is the role of Bmp3 in regulation of
bone formation. Similar to many osteogenic BMP ligands, Bmp3 is
expressed in osteoblasts [17,45,46,53,54]. However, while canon-
ical BMP signaling is required for bone formation (reviewed in
[74]), Bmp3 knockout mice have high bone mass [15] and
overexpression of BMP3 leads to spontaneous rib fractures in mice
[22], indicating that BMP3 is a negative regulator of osteogenesis.
As such, the identification of a highly-conserved repressive element
near the Bmp3 promoter could determine mechanisms to reduce
Bmp3 expression in diseases of low bone mass such as osteopenia
and osteoporosis.
Concluding Remarks
We identified the minimal Bmp3 promoter from M. musculus and
determined that this region is highly conserved with R. norvegicus.
We also found that a highly conserved upstream region abutting
the minimal promoter is able to repress the minimal promoter. A
portion of this region is conserved among all available eutherian
mammal genomes (47/47), but not in any non-eutherian animal
(0/136). We also identified multiple conserved transcription factor
binding sites in the Bmp3 upstream ECR. Collectively, these
findings suggest that the high level of conservation of the Bmp3
upstream ECR may preserve common cis-regulatory elements that
govern Bmp3 expression across eutherian mammals.
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Figure S1 Bmp3 expression analysis. RT-PCR for Bmp3 in
HEK293T cells (A), UMR-106 cells (B), primary mouse calvarial
osteoblasts(cOBs, C), and C2C12 cells 9D) compared to Hprt
housekeeping control. Newborn mouse hind limb cDNA was used
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Intervening lanes from a single gel removed in A (indicated by
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Figure S2 Determination and individual nucleotide
conservation of the minimal Bmp3 upstream ECR
(minECR) present in all RefSeq mammals. BLASTN
(Version 2.2.26+) was used to align the M. musculus: H. sapiens
CoreECR sequence to all sixteen available eutherian mammal
RefSeq genomes in order to identify the Bmp3 upstream ECR
shared with M. musculus. Each full-length ECR was then aligned
using MUSCLE in MEGA5 [64], identifying a minimal Bmp3
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(319 nt as shown when including insertions found in some species).
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National Laboratory’s Simple Consensus Maker. Uppercase letters
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